Nature Communications, Published online: 16 November 2020; doi:10.1038/s41467-020-19507-0 Gene and cell therapy products approved over the past decade in Europe and North America have provided new therapeutic options for single gene disorders and for hematologic malignancies.

Source: Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?

Leave a Reply

Your email address will not be published.